Discovery of SIRT3 Inhibitors Using SAMDI Mass Spectrometry

Lysine acetylation plays a critical role in cellular regulation and is implicated in human disease. Sirtuin deacetylases remove acetyl groups from modified lysine residues, and sirtuin 3 (SIRT3) has been identified as a target for cancer therapeutics. Robust and high-throughput screening methods for these targets will be important to the development of therapeutics. This article describes the use of self-assembled monolayer desorption/ionization mass spectrometry, or SAMDI-MS—a label-free drug discovery tool—to characterize SIRT3 activity and discover inhibitors. SAMDI-MS was used to analyze a peptide array having 361 distinct acetylated peptides to identify an active SIRT3 substrate (GYKAcRGC). This peptide was used in a screen of 100,000 small molecules to identify inhibitors of SIRT3. A total of 306 SIRT3 inhibitors were identified, with one compound, SDX-437, having an IC50 of 700 nM with >100-fold selectivity for SIRT3 over SIRT1.

[1]  J. Hermes,et al.  Use of High-Throughput Mass Spectrometry to Reduce False Positives in Protease uHTS Screens , 2015, Journal of biomolecular screening.

[2]  K. Swinger,et al.  A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening , 2015, Journal of biomolecular screening.

[3]  M. Mrksich,et al.  Rapid evaluation and screening of interfacial reactions on self-assembled monolayers. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[4]  D M Schmatz,et al.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Sternglanz,et al.  Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. , 2007, Structure.

[6]  Venkataraman Thanabal,et al.  SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1♦ , 2010, The Journal of Biological Chemistry.

[7]  Tram A. Ngo,et al.  TR-FRET-Based High-Throughput Screening Assay for Identification of UBC13 Inhibitors , 2012, Journal of biomolecular screening.

[8]  D. Riester,et al.  Histone deacetylase inhibitor assay based on fluorescence resonance energy transfer. , 2007, Analytical biochemistry.

[9]  Mark W. Craven,et al.  Sirt3 Substrate Specificity Determined by Peptide Arrays and Machine Learning , 2022 .

[10]  Kai Zhang,et al.  Protein lysine acetylation analysis: current MS-based proteomic technologies. , 2013, The Analyst.

[11]  N. Balthasar,et al.  SIRT3: A Central Regulator of Mitochondrial Adaptation in Health and Disease. , 2013, Genes & cancer.

[12]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[13]  M. Mrksich,et al.  Profiling the selectivity of DNA ligases in an array format with mass spectrometry , 2009, Nucleic acids research.

[14]  M. Mrksich,et al.  A method for connecting solution-phase enzyme activity assays with immobilized format analysis by mass spectrometry. , 2004, Analytical chemistry.

[15]  G. Brosch,et al.  Biochemical methods for analysis of histone deacetylases. , 1998, Methods.